4//SEC Filing
MACDONALD JOHN R 4
Accession 0001271137-05-000014
CIK 0000702131other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 12:58 PM ET
Size
22.2 KB
Accession
0001271137-05-000014
Insider Transaction Report
Form 4
MGI PHARMA INCMOGN
MACDONALD JOHN R
Sr. VP, Research & Development
Transactions
- Sale
Common Stock
2005-02-15$25.03/sh−20,250$506,868→ 11,676 total - Exercise/Conversion
Employee Stock Option-Right to Buy
2005-02-15−20,000→ 0 totalExercise: $1.97From: 2002-01-14Exp: 2008-01-14→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2005-02-15$2.29/sh+250$572→ 11,926 total - Exercise/Conversion
Common Stock
2005-02-15$1.97/sh+20,000$39,376→ 31,926 total - Exercise/Conversion
Common Stock
2005-02-14$2.41/sh+7,750$18,649→ 19,426 total - Exercise/Conversion
Common Stock
2005-02-14$2.29/sh+2,250$5,150→ 21,676 total - Sale
Common Stock
2005-02-14$25.00/sh−10,000$250,000→ 11,676 total - Exercise/Conversion
Employee Stock Option-Right to Buy
2005-02-14−2,250→ 250 totalExercise: $2.29From: 2001-11-11Exp: 2007-11-11→ Common Stock (2,250 underlying) - Exercise/Conversion
Employee Stock Option-Right to Buy
2005-02-15−250→ 0 totalExercise: $2.29From: 2001-11-11Exp: 2007-11-11→ Common Stock (250 underlying) - Exercise/Conversion
Employee Stock Option-Right to Buy
2005-02-14−7,750→ 0 totalExercise: $2.41From: 2001-01-14Exp: 2007-01-14→ Common Stock (7,750 underlying)
Holdings
- 25,030(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]These shares sold pursuant to a 10(b)5-1 plan filed on November 9, 2004.
- [F2]Filing dated July 16, 2004 incorrectly reported a tandem Limited Stock Appreciation Right which is not attached to this option grant.
Documents
Issuer
MGI PHARMA INC
CIK 0000702131
Entity typeother
Related Parties
1- filerCIK 0001228879
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 12:58 PM ET
- Size
- 22.2 KB